Medicines and leaflets
Results for the medicine lamivudin
20 results shown
Refine your search
-
-
EPIVIR 10mg/ml oral solution VIIV ORIGINAL MEDICINE
-
EPIVIR 150mg film-coated tablets VIIV ORIGINAL MEDICINE
-
EPIVIR 300mg film-coated tablets VIIV ORIGINAL MEDICINE
-
LAMIVUDINA AUROBINDO 150mg film-coated tablets
-
LAMIVUDINA MYLAN 150mg film-coated tablets VIATRIS LIMITED
-
LAMIVUDINA MYLAN 300mg film-coated tablets VIATRIS LIMITED
-
LAMIVUDINA TEVA 100mg film-coated tablets
-
LAMIVUDINA TEVA PHARMA B.V 300mg film-coated tablets
-
LAMIVUDINA/TENOFOVIR DISOPROXIL CIPLA 300mg/245mg film-coated tablets
-
LAMIVUDINA/ZIDOVUDINA ACCORD 150mg/300mg film-coated tablets
-
LAMIVUDINA/ZIDOVUDINA AUROBINDO 150mg/300mg film-coated tablets
-
LAMIVUDINA/ZIDOVUDINA MYLAN 150mg/300mg film-coated tablets
-
LAMIVUDINA/ZIDOVUDINA SANDOZ 150mg/300mg film-coated tablets
-
LAMIVUDINA/ZIDOVUDINA TEVA 150mg/300mg film-coated tablets
-
LAMIVUDINA/ZIDOVUDINA VIATRIS 150mg/300mg film-coated tablets VIATRIS LIMITED
-
LAMIVUDINE TEVA 100mg film-coated tablets
-
LAMIVUDINE TEVA PHARMA B.V 150mg film-coated tablets
-
LAMIVUDINE TEVA PHARMA B.V 300mg film-coated tablets
-
ZEFFIX 100mg film-coated tablets GLAXO SMITH KLINE ORIGINAL MEDICINE
Results for the substance lamivudin
-
abacavir + lamivudine
Indicated for: HIV-1 infection
J05AR02 Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections, combinations
-
abacavir + lamivudine + zidovudine
Indicated for: HIV-1 infection
J05AR04 Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections, combinations
-
dolutegravir + abacavir + lamivudine
Indicated for: HIV-1 infection
J05AR13 Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections, combinations
-
dolutegravir + lamivudine
Indicated for: HIV-1 infection
J05AR25 Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections, combinations
-
doravirine + lamivudine + tenofovir disoproxil
Indicated for: HIV-1 infection
J05AR24 Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections, combinations
-
lamivudine
Indicated for: HIV-1 infection; chronic hepatitis B
J05AF05 Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors
-
lamivudine + tenofovir disoproxil
Indicated for: HIV-1 infection
J05AR12 Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections, combinations
-
lamivudine + zidovudine
Indicated for: HIV-1 infection
J05AR01 Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections, combinations